Asthma, COPD, Lung Cancer News | Treatment & Research Articles
Over the past 5 years, telehealth has grown from an emergency stopgap during the COVID-19 pandemic to a cornerstone of modern health care. Whether for routine check-ups, mental …
GOLD COPD Report 2025: Key Spirometry and Drug Updates
2024年11月22日 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, …
ILD Short-Term Survival May Be Improved With Pulmonary …
1 天前 · Pulmonary rehabilitation (PR) may improve survival at 5 years in patients with interstitial lung disease (ILD), according to study findings published in Chest.. Researchers assessed …
Fostamatinib Does Not Improve Outcomes in Those With COVID …
2 天之前 · Fostamatinib vs placebo does not decrease oxygen use among adults hospitalized with COVID-19 and hypoxemia during the Omicron era, according to study findings published in …
COPD: Early Disease May Be Linked to Impaired FEV1/FVC …
2025年1月8日 · Individuals with early-onset chronic obstructive pulmonary disease (COPD) and rapidly progressive pre-COPD frequently have a decades-long history of wheeze and an …
Lung Transplant: Early Rejection Safely Detected by Transbronchial …
2 天之前 · Early acute rejection (AR) following lung transplantation can be effectively detected and graded by transbronchial biopsy (TBB) via bronchoscopy, with a low rate of pneumothorax …
COVID Antiviral, mAb Treatments Reduce Mortality and …
5 天之前 · Certain antiviral drugs and monoclonal antibody (mAb) therapies continue to lower mortality risk and reduce hospitalization among individuals infected with the SARS-CoV-2 …
Dupixent Approved as Add-On Maintenance Therapy in COPD
2024年10月1日 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive …
Monoclonal Antibodies in Eosinophilic COPD Safely Reduce …
2025年1月14日 · Treating eosinophilic chronic obstructive pulmonary disease (COPD) with monoclonal antibodies significantly reduces exacerbations and has an acceptable safety and …
Nebulized Anticholinergic Therapy for Maintenance Treatment of …
For select patients with COPD, nebulized drugs might offer an alternative to a breath-actuated, hand-held inhaler. 5 Adherence to inhaled medication in patients with COPD is low, with the …